Mark David Slager Net Worth & Insider Trades
Mark David Slager Oramed Pharmaceuticals Inc
What is Mark David Slager's Net Worth?
The current estimated net worth of Oramed Pharmaceuticals Inc's Mark David Slager is estimated to be about $2.86M . Mark David Slager owns about 896,364 units of Oramed Pharmaceuticals Inc common stock. In the last 3 years at Oramed Pharmaceuticals Inc, Mark David Slager has sold an estimated value of $0 worth.
What is Mark David Slager's Past Insider Trading?
Mark David Slager's largest purchase order was 51,292 units , worth over $800.74K on February 6, 2014. In total, Mark David Slager has made about 7 transactions over 3 years of their time at Oramed Pharmaceuticals Inc. Mark David Slager usually trades in December, October, February, July, June, March and November, with the busiest year in 2014. The most recent transaction was a purchase order of 0 unit , worth over $0 on October 20, 2015.
David Slager
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Mark David Slager's' Mailing Address?
- Mailing address is 152 West 57th Street, 9th Floor New York NY 10019 NY
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
What are Oramed Pharmaceuticals Inc's Past Insider Trades?
Oramed Pharmaceuticals Inc's most recent insider trade came on March 16, 2023 by Nadav Kidron who bought 26,000 units worth $53.01K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.59M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO, Miriam Kidron, Chief Scientific Officer, and Leonard Sank, Director .
ORAMED PHARMACEUTICALS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||